Novel Bispecific Innate Cell Engager AFM28 in Combination with Allogeneic NK Cells for the Treatment of CD123+ Acute Myeloid Leukemia and Myelodysplastic Syndrome
Jens Pahl et al.
NK2022
Jens Pahl et al.
NK2022
Anthony El-Khoueiry et al.
AACR 2022
Reusch et al.
Antibodies. 2022; 11(1):12
Götz et al.
ASH 2021
Reusch et al.
ASH 2021
Pinto et al.
SITC 2021
Pinto et al.
SITC 2021
Zambarda et al.
SITC 2021
Pahl et al.
AACR-NCI-EORTC 2021 - AFM24
Wingert et al.
mAbs 2021; 13(1): 1950264